Findell Capital Management »

Vor Biopharma shares owned by Findell Capital Management

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by Findell Capital Management from 13F filings

Historical chart of Findell Capital Management investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by Findell Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by Findell Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $3.0M 231k 13.08

More positions owned by Findell Capital Management

Liquidia Corporation Com New (LQDA)
Establishment Labs Holdings Ord (ESTA)
Root Cl A New (ROOT)
Dave Class A Com New (DAVE)
Turning Pt Brands (TPB)
Oportun Finl Corp (OPRT)
Super Group Sghc Ord Shs (SGHC)
Geo Group Inc/the reit (GEO)
Celsius Hldgs Com New (CELH)
eHealth (EHTH)
Abivax Sa Sponsored Ads (ABVX)
Stride (LRN)
Adma Biologics (ADMA)
Vor Biopharma Com New (VOR)
Mineralys Therapeutics (MLYS)

View all positions for Findell Capital Management

Top funds holding Vor Biopharma

Fcpm Iii Services B.v.
Frazier Life Sciences Management
RA Capital Management
VR Adviser
Paradigm Biocapital Advisors
Dr. Jeffrey R. Jay, M.D.
Susquehanna International
Caligan Partners
Vanguard Group
BlackRock
Sphera Funds Management
Laurion Capital Management
UBS Group
FMR
Findell Capital Management

View all funds holding Vor Biopharma